Infectious Agents and Cancer Blog
Unofficial Impact Factor for Infectious Agents and Cancer
BioMed Central recently released the 2010 IAC unofficial IF of 2.33. An excellent result for a recently established journal.
For any journal to have an Impact Factor it must be tracked by Thomson Reuters (ISI) for three years. Although many BioMed Central journals are tracked by Thomson Reuters, others are still relatively new. For further information the Impact Factor Web Page of BioMed Central should be visited. The listed tables show those journals that are already tracked by Thomson Reuters (ISI) and so already have Impact Factors, and journals that are due Impact Factors for which their unofficial Impact Factors has been calculated. Note that in several cases the figures are artificially low, as they are based on a single year of citation data rather than the usual two.Thomson Reuters (ISI) is currently considering additional BioMed Central journals for tracking. If the journal you are interested in is not currently tracked, you can recommend it to Thomson Reuters (ISI) for tracking.
Two other citation tracking services (Scopus and Google Scholar) both track citations for all BioMed Central journals.
The SCImago Journal Rank(SJR) is also a free alternative journal citation-metric based on citation information from Scopus.
SJR is currently ranking the IAC journal in the second Quartile of all worldwide journals dealing with Epidemiology (occupying the position number 20) and Oncology (# 78) and in the first Quartile of those focused on Infectious Diseases (#23).
Moreover the IAC journal is now on Twitter at @IAC_journal.
Posted by Franco Buonaguro at 11:07 Comments (0)
Carcinogenic Classification of HPVs
There is still turmoil on the classification of HPV carcinogenicity, particularly for the weakly carcinogenic types. 
The subject has been discussed at the IARC Meeting B on biological carcinogenic agents, and Mark Schiffman is reporting in the current IAC Editorial the scientific approach used for the re-classification.
Not all scientists, neither all IARC participants, fully agree on this subject and Mark is again stressing this concept starting with a clear sentence "We do not agree on everything" his presentation (that will likely become a renowned presentation) at Malmo 25th IPV Conference, 
available at the Conference WebCast:
HPV: natural history of the infection from the epidemiological and clinical perspective
(by M. Schiffman)
Posted by Franco Buonaguro at 12:53 Comments (1)
Welcome to IAC Blog
Few weeks ago, in order to celebrate the recently awarded 2008 Nobel Prizes in Physiology or Medicine to Harald zur Hausen, Françoise Barrè-Sinoussi and Luc Montagnier, we felt the need to create a blog for fast track communications and to allow IAC readers/members to express their thoughts/comments and/or to submit their Posts.
The first reaction to the News of the Nobel Prize Awards was of sincere enthusiasm for the recognition of the relevant contribution of Viral Oncology to Basic Science and in general to BioMedical Research. The Nobel prize relevance, at the personal level, was much higher for our relationship with all three awardees. Moreover the presence of Prof. zur Hausen in our Editorial Board was a further element of delight.
The wonderful feelings of that news were only shadowed by the absence of Prof. Gallo in association with the HIV discovery. Very likely the long-lasting querelle between the NIH and the Pasteur Institute (legally settled few years ago) has played a major role on the decision of the Nobel Prize Committee. In 50 years, those of us still alive will know the full story of this award, and we hope that it will not be similar to that of the Fibinger Nobel Prize, whose backstage has been recently published by Stolt CM, Klein G and Jansson AT in An analysis of a wrong Nobel Prize-Johannes Fibiger, 1926: a study in the Nobel archives (Adv Cancer Res. 2004;92:1-12).
Posted by Franco Buonaguro at 16:03 Comments (2)